IL6 upregulation in the brain therefore is consistent with the cytokine ‘storm’ observed in COVID-19 and consequently plays a critical role in driving the thrombotic pathology observed in COVID-19 patients’ brain, and can be potentially be targeted for ameliorating this risk in patients. The gene discussed is IL6; the disease is COVID-19.